(NRSNW - NEUROSENSE THERAPEUTICS LTD)

company profile

Neurosense Therapeutics Equity Warrant Exp 9Th Nov 2026 (NRSNW) is trading at 0.05

Open Price

0.046

Previous close

0.05

Previous close

0.05

P/E Ratio

0

Primary exchange

NASDAQ-NMS

ISIN

IL0011811630